| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |